Novo Partners With Anthropic to Speed Up Drug Discovery Using Claude

The Wall Street Journal
Read full post
Novo and Anthropic have partnered to accelerate drug discovery by creating specialized AI-driven solutions and workflows using Anthropic's Claude model. This collaboration targets major challenges in pharmaceutical research.

More in Healthcare

Healthcare2 min read

ByteDance’s AI drug unit Anew Labs raises $290M at $1.5B valuation, Reuters reports

The Next Web
Healthcare5 min read

University of Manchester Uses NVIDIA Earth-2 to Forecast Air Pollution Across the UK

Nvidia Blog
Healthcare4 min read

Medtronic Wins FDA Clearance for LigaSure RAS Maryland on Hugo Robot

Unite.AI